RE: NEW CEO INTERVIEW OUT!26 Sep 2024 10:04
Here to enhance shareholder value…this SP is on its knees so what timing for new investors!
Dennis Purcell commented: "I am thrilled to join Graft Polymer's Board at such an exciting juncture. The Company's collaboration model, starting with Awakn, is poised to make a significant impact in the biopharmaceutical sector - specifically in the area of treating addiction and mental health issues, where there is an enormous opportunity. I look forward to working closely with my fellow Board members and the management team to drive growth, enhance shareholder value, and bring transformational solutions to patients in need."